On May 12, 2026, The Lancet published a landmark paper announcing the official renaming of Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) — ending a decade-long global consensus process involving 22,000 experts across 195 countries. The change reflects what researchers and patients have long argued: the old name was clinically misleading (many patients don't have ovarian cysts) and carried stigma that delayed diagnosis and undermined patient advocacy.

Why It Matters

This is the most significant nomenclature change in reproductive health in decades. The renaming signals a broader shift toward treating hormonal and metabolic conditions affecting people with ovaries as systemic health issues rather than siloed "women's problems." For the sextech and femtech industries, PMOS-related products and services represent a massive addressable market — 170 million patients globally, many of whom experience sexual dysfunction, reduced libido, and pain as part of their condition. Companies that build PMOS-aware features into their platforms will have a competitive advantage as clinical and consumer awareness catches up to the new terminology.

The condition affects more than 170 million people worldwide and is the leading cause of anovulatory infertility. Despite its prevalence, PCOS has been chronically underfunded and misunderstood, with patients reporting an average 2-year diagnostic delay. The new name — Polyendocrine Metabolic Ovarian Syndrome — captures the condition's systemic nature: it's an endocrine and metabolic disorder, not simply an ovarian cyst problem. A survey conducted as part of the consensus process found 86% of patients and 71% of clinicians supported the change.

The renaming has immediate implications for the femtech industry. Companies building around cycle tracking, hormone monitoring, and reproductive health — including Natural Cycles, Clue, Flo Health, and the recently funded Chexy ($30M Series A for AI-powered menstrual health) — will need to update product language, clinical references, and marketing materials. Insurance coding and billing systems will require updates. For patients, the new name provides clinical language that more accurately describes their experience and may reduce the shame and confusion that the old terminology perpetuated.

Sources

Update — 2026-05-27

Initial entry — story first created.